MBL

Anti-5-methylcytidine (m5C) mAb

Product Code:
 
MBL-D346-3
Product Group:
 
Primary Antibodies
Supplier:
 
MBL
Host Type:
 
Mouse
Antibody Isotype:
 
IgG2a λ
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
FMC-9
Regulatory Status:
 
RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunocytochemistry (ICC)
  • Immunohistochemistry (IHC)
  • Immunoprecipitation (IP)
  • Western Blot (WB)
Shipping:
 
4°C
Storage:
 
-20°C
1 / 10
2 / 10
3 / 10
4 / 10
5 / 10
6 / 10
7 / 10
8 / 10
9 / 10
10 / 10
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-D346-3100 ul£346.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Applications:
WB - Dot blot: Can be used. ICC - 1 or 5 ug/mL (refer to datasheet) IHC - 10 ug/mL (For nuclear staining) ELISA - Inhibition ELISA (Info. from the licenser)
Background:
5-Methylcytosine (5mC), a modified nucleobase derived from cytosine, is present in both DNA and RNA molecules. 5mC in DNA is an essential epigenetic mark associated with gene silencing and genome stability during embryonic development. 5mC in ribonucleoside, called 5-methylcytidine (m5C), is involved in structural stability, aminoacylation and codon recognition of tRNA. In rRNA, m5C affects translational fidelity and tRNA recognition. m5C-modified nucleobase also have been identified in mRNA and other non-coding RNA but the biological functions are still unclear. m5C is detected not only in tissues and cells but also in urine. It is reported that the levels of m5C change in urine or tissues from patients with various diseases such as bladder, breast and colon cancers.
Formulation:
1 mg/mL in PBS/50% glycerol, pH 7.2
Immunogen Translated:
KLH-conjugated 5-methylcytidine (KLH-m5C)
Target:
5-methylcytidine (m5C)

Documents